These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2106310)

  • 1. Tumor immunization. Improved results after vaccine modified with recombinant interferon gamma.
    Sigal RK; Lieberman MD; Reynolds JV; Williams N; Ziegler MM; Daly JM
    Arch Surg; 1990 Mar; 125(3):308-12. PubMed ID: 2106310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vaccinia expressing interleukin-2 for cancer gene therapy.
    Qin H; Chatterjee SK
    Cancer Gene Ther; 1996; 3(3):163-7. PubMed ID: 8725880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to mouse neuroblastoma C1300. I. Preliminary observations on cell-mediated immune responses.
    Phillips ME; Cipuzak PM; Penta DD; Schachner M
    J Natl Cancer Inst; 1977 Oct; 59(4):1215-9. PubMed ID: 903996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.
    Watanabe Y; Kuribayashi K; Miyatake S; Nishihara K; Nakayama E; Taniyama T; Sakata T
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9456-60. PubMed ID: 2512580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma.
    Iinuma H; Okinaga K; Fukushima R; Inaba T; Iwasaki K; Okinaga A; Takahashi I; Kaneko M
    J Immunol; 2006 Mar; 176(6):3461-9. PubMed ID: 16517714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of natural killer cells in neuroblastoma.
    Reynolds JV; Shou J; Choi H; Sigal R; Ziegler MM; Daly JM
    Arch Surg; 1989 Feb; 124(2):235-9. PubMed ID: 2492800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
    Hu ZY; He P; Fang X; Qiu SH; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):810-4. PubMed ID: 19103120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
    Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
    Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.
    Yoshida H; Enomoto H; Miyauchi M; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M
    Int J Oncol; 1998 May; 12(5):1067-71. PubMed ID: 9538130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells.
    Lauro G; Businaro R; Butler RH; Revoltella R
    J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage.
    Zheng J; Liu P; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):1006-14. PubMed ID: 23169344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
    Dai W; Huangfu Y; Zheng B
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of interleukin-2 immunotherapy with L-arginine.
    Lieberman MD; Nishioka K; Redmond HP; Daly JM
    Ann Surg; 1992 Feb; 215(2):157-65. PubMed ID: 1546902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to mouse neuroblastoma C1300. II. Cell-mediated kinetics and specificity studies.
    Della Penta D; Cipuzak PM; Phillips ME
    Int Arch Allergy Appl Immunol; 1982; 69(4):322-9. PubMed ID: 7141715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy.
    Sigal RK; Lieberman MD; Reynolds JV; Shou J; Ziegler MM; Daly JM
    J Pediatr Surg; 1991 Apr; 26(4):389-95; discussion 395-6. PubMed ID: 1905348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
    Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
    Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.